Literature DB >> 23252632

Prevalence of stroke among patients with paroxysmal supraventricular tachycardia.

Béatrice Brembilla-Perrot1, Julien Delobelle.   

Abstract

BACKGROUND: To assess the prevalence of unexplained stroke in patients with paroxysmal supraventricular tachycardia (SVT). The risk of atrial fibrillation (AF) is well known and risk of stroke can be expected.
METHODS: A total of 1,362 patients were referred for SVT, confirmed by electrophysiological study. Patients with anterograde conduction over accessory pathway (AP) were excluded. Clinical and electrophysiological data were collected.
RESULTS: Stroke was noted in 38 patients with a prevalence of 2.8%. Patients with stroke were older (62 ± 12 years vs 49 ± 19 years; P < 0.0001). Heart disease (34% vs 10%; P < 0.0001) and AF history (10.5% vs 2%; P < 0.001) were more frequent. Male gender was as frequent in patients with and without stroke (45% vs 39.5%; NS). SVT mechanism was similar: AV reentrant tachycardia over concealed AP was 10.5% in patients with stroke and 18.5% in other patients (NS). Atrioventricular node reentrant tachycardias represent other mechanisms. After 2.6 ± 2.5 years, SVT ablation was performed less frequently in patients with stroke (37% vs 63%; P < 0.001); three patients without previous stroke presented a stroke. AF and cardiovascular death were more frequent in patients with stroke (21% vs 4.6%; P < 0.000), (8% vs 2%; P < 0.008). Note that 7.6% of patients treated with ablation and 6% of patients without ablation had an event (stroke, AF, death; NS).
CONCLUSIONS: Unexplained stroke was rare in patients with SVT, noted in 2.8% of this population. Old age and AF history were the predictors of stroke. These patients had a risk of adverse events as AF or death. SVT ablation did not seem to reduce the risk of new stroke, AF or death. ©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23252632     DOI: 10.1111/pace.12046

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden.

Authors:  Per Rosengren; Xinjun Li; Jan Sundquist; Kristina Sundquist; Bengt Zöller
Journal:  Ann Med       Date:  2018-10-15       Impact factor: 4.709

Review 2.  Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.

Authors:  Brandon W Calenda; Valentin Fuster; Jonathan L Halperin; Christopher B Granger
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

3.  Paroxysmal supraventricular tachycardia and risk of ischemic stroke: A systematic review and meta-analysis.

Authors:  Pongprueth Rujirachun; Phuuwadith Wattanachayakul; Arjbordin Winijkul; Patompong Ungprasert
Journal:  J Arrhythm       Date:  2019-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.